
Contact us
About company
ElyssaMed® is a spin-off of Gustave Roussy Institute and develops an active immunotherapy against lung cancer NSCL.
FR
Unknown
Not verified company
ElyssaMed® is a spin-off of Gustave Roussy Institute and develops an active immunotherapy against lung cancer NSCL.